Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)
Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Fairfield, California, United States, 94535
- David Grant Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or Female
- Age ≥18
- Willing to exercise five days per week for four weeks, performing each component of the AF PFT at least once per week
- Willing to adhere to a prescribed supplementation regimen, including spaced dosing two times per day
- Able to meet all study follow-up and testing requirements as outlined in section 6.4 of this protocol
Exclusion Criteria:
- History of:
- Chronic kidney dysfunction
- Liver failure
- Rhabdomyolysis
- Compartment syndrome
- Current
- Pregnancy
- Musculoskeletal injury
- Fitness exemption from any component of the AF PFT (e.g. AF 469, "profile")
- Kidney injury
- Diabetes
- Hypertension, requiring medication
- Allergy to rice
- Admission to the hospital within the past 30 days
- Creatine supplementation within the past 90 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
30g white rice flour
|
rice flour powder matched for color, appearance, taste, and solubility
|
|
Experimental: Low dose
5g/day Creatine Monohydrate (25g white rice flour) for 28 days
|
rice flour powder matched for color, appearance, taste, and solubility
Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace
|
|
Experimental: Loading dose
Creatine Monohydrate 20g/day (10g white rice flour) for 7 days, followed by maintenance dose of Creatine Monohydrate 5g/day (25g white rice flour) for the remaining 21 days
|
rice flour powder matched for color, appearance, taste, and solubility
Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace
|
|
Experimental: High dose
High dose of Creatine Monohydrate 20g/day (10g white rice flour) for the entire 28 day period
|
rice flour powder matched for color, appearance, taste, and solubility
Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the effect of creatine supplementation on anaerobic performance in the PFT by measuring change in repetitions of push-ups and sit-ups.
Time Frame: 28 days
|
An initial mock AF PFT will be administered.
Individual component raw numbers, scores, and composite scores will be recorded.
Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week.
Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT.
The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores
|
28 days
|
|
Determine the effect of creatine supplementation on aerobic performance in the PFT by measuring change in 1.5 mile run time.
Time Frame: 28 days
|
An initial mock AF PFT will be administered.
Individual component raw numbers, scores, and composite scores will be recorded.
Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week.
Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT.
The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores
|
28 days
|
|
Determine the effect of creatine supplementation on body composition as it relates to the PFT by measuring change in abdominal circumference
Time Frame: 28 days
|
An initial mock AF PFT will be administered.
Individual component raw numbers, scores, and composite scores will be recorded.
Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week.
Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT.
The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores
|
28 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine how renal function is affected by creatine supplementation by measuring renal function labs (BUN/Creatinine/GFR-with Cys C) before and after the study period.
Time Frame: 28 days
|
Labs will be draw before initiation of prescribed treatment.
Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw
|
28 days
|
|
Assess for possible liver damage resulting from creatine supplementation by measuring liver function labs (AST/ALT/Alk Phos) before and after the study period.
Time Frame: 28 days
|
Labs will be draw before initiation of prescribed treatment.
Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw
|
28 days
|
|
Evaluate the risk of rhabdomyolysis with creatine supplementation by measuring creatine kinase before and after the study period.
Time Frame: 28 days
|
Labs will be draw before initiation of prescribed treatment.
Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw
|
28 days
|
|
Treatment compliance as determined by medication diary.
Time Frame: 28 days
|
Participants will be given a log book to record their supplement compliance.
They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are appropriately taking their supplements.
Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book
|
28 days
|
|
Quality of workout as determined by exercise diary.
Time Frame: 28 days
|
Participants will be given a log book to record their exercise history.
They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are meeting the requirement of exercising 4 out of 5 days/week.
Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book
|
28 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Stephen D Kasteler, MD, US Air Force
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- FDG20150021H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.